Cefepime and aztreonam shortages: We've run out of ammo [6];Desabastecimiento de cefepima y aztreonam: Nos quedamos sin municiones

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 25, Issue 5, 2007, Pages 360-361

  Grau, Santiago ^a   Luque, Sonia ^a   Berenguer, Nuria ^a   Mateu De Antonio, Javier ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; ENTEROBACTER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; LETTER; NONHUMAN; PRESCRIPTION;

EID: 34547617176     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13102278     Document Type: Article

References (8)

1. Méndez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ. Impact of a piperacilin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant Enterococci and Clostridium difficile infections. Pharmacotherapy. 2006;26:61-7.
2. Ferrández O, Mateu de Antonio J, Grau S. Effects of antimicrobial drug shortages. Am J Health Syst Pharm. 2005;62:1444.
3. Strausbaugh LJ, Jernigan DB, Liedtke LA. National shortages of antimicrobial agents: results of 2 surveys from the Infectious Diseases Society of America Emerging Infections Network. Clin Infec Dis. 2001;33:1495-501.
4. Kollef MH. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-74.
5. Fritsche TR, Sader HS, Jones RN. Comparative activity and spectrum of broad-spectrum beta-lactams (cefepima, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 surveillance program (North America: 2001-2002). Diagn Micro Infect Dis. 2003;435-40.
6. Chapman TM, Perry CM. Cefepima: a review of its use in the management of hospitalized patients with pneumonia. Am J Respir Med. 2003;2:75-107.
7. Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis. 2006;42 Suppl 4:153-63.
8. Asensio A, Cantón R, Vaqué J, Rosselló J, Arribas JL. Antimicrobial use in Spanish hospitals (EPINE, 1990-1999). Med Clin. 2002;118:731-6.